What is OS Therapies's enterprise value?

OS Therapies (OSTX) reported enterprise value of $68.73M in Q1 2026.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.

OS Therapies OSTX Enterprise value

Enterprise value at other companies

ImmunomeIMNM

$1.9B+470%

Avalo TherapeuticsAVTX

$315.24M+909%

ImmunityBio, Inc.IBRX

$8.16B+187%

Arcus BiosciencesRCUS

$2.62B+275%

Other financials

Income statement

See full

Operating income-$10.2M-103%

Net income-$10.4M-168%

EPS (diluted)-$0.27-50.0%

Balance sheet

See full

Cash & equivalents$917.6K-69.1%

Total debt$20.0M—

Total equity-$10.8M-159%

Total assets$7.3M+71.7%

Cash flow

See full

Operating cash flow-$4.6M-32.6%

CapEx$316.4K—

Free cash flow-$3.7M—

Valuation

See full

Market cap$84.62M+66.4%

Returns & leverage

See full

Return on equity470%—

Debt / equity-1.8×—

Current ratio0.1×-1.1×

Where this comes from

Calculated from OS Therapies’s reported figures.

$49.7Mmarket cap+$20.0Mtotal debt−$917.6Kcash and equivalents=$68.73M

The official record: OS Therapies’s 10-Q, filed May 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about OS Therapies's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is OS Therapies's enterprise value?: OS Therapies (OSTX) reported enterprise value of $68.73M in Q1 2026.
What does enterprise value mean?: Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.